title: Influence of 'nonhematological' doses of erythropoietin on lipid-carbohydrate metabolism and life quality in hemodialysis patients.
authors.forename: J
authors.initials: J
authors.lastname: Manitius
authors.forename: M
authors.initials: M
authors.lastname: Szołkiewicz
authors.forename: J
authors.initials: J
authors.lastname: Myśliwska
authors.forename: K
authors.initials: K
authors.lastname: Zorena
authors.forename: A
authors.initials: A
authors.lastname: Myśliwski
authors.forename: Z
authors.initials: Z
authors.lastname: Jakubowski
authors.forename: W
authors.initials: W
authors.lastname: Lysiak-Szydłowska
authors.forename: B
authors.initials: B
authors.lastname: Rutkowski
mesh_terms: D000740:Anemia / Q000188:drug therapy; D050260:Carbohydrate Metabolism; D004305:Dose-Response Relationship, Drug; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D011788:Quality of Life; D006435:Renal Dialysis / Q000009:adverse effects
chemical_list: D004921:Erythropoietin